Aimed Bio Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	5,023	-3,304	-9,023	-6,168
Depreciation & Amortization	1,382	1,464	1,058	780.45
Loss (Gain) From Sale of Assets	16.22	-0.66	7.24	12.95
Loss (Gain) From Sale of Investments	317.63	-96.75	1,084	716.25
Stock-Based Compensation	1,315	667.74	1,061	1,015
Other Operating Activities	12,254	3,753	1,518	-87.96
Change in Accounts Receivable	-3,300	-6,922	45.46	-38.64
Change in Unearned Revenue	-454.55	-499.72	1,154	140.79
Change in Other Net Operating Assets	1,308	64.83	450.07	-278.35
Operating Cash Flow	17,860	-4,874	-2,644	-3,908
Capital Expenditures	-353.69	-223.73	-795.7	-451.6
Sale of Property, Plant & Equipment	-	23.14	-	0.63
Cash Acquisitions	-	-	-	-0.04
Sale (Purchase) of Intangibles	-8.94	-1,456	-	-69.8
Investment in Securities	-33,390	-14,412	-13,472	5,888
Other Investing Activities	-182.03	-319.85	-232.63	-276.82
Investing Cash Flow	-33,935	-16,389	-14,500	5,090
Long-Term Debt Repaid	-538.39	-475.11	-454.13	-257.1
Net Debt Issued (Repaid)	-538.39	-475.11	-454.13	-257.1
Issuance of Common Stock	76,066	-	5,220	161.66
Other Financing Activities	-	-	76.8	71.83
Financing Cash Flow	118,462	24,270	15,734	-23.61
Foreign Exchange Rate Adjustments	-467.7	18.76	0.61	5.23
Miscellaneous Cash Flow Adjustments	-0	-	0	-
Net Cash Flow	101,920	3,026	-1,410	1,163
Free Cash Flow	17,506	-5,098	-3,440	-4,360
Free Cash Flow Margin	37.03%	-43.35%	-2009.11%	-3924.65%
Free Cash Flow Per Share	352.04	-143.49	-100.72	-130.42
Cash Interest Paid	51.71	87.55	118.44	122.89
Cash Income Tax Paid	3,295	130.5	-5.47	13.28
Levered Free Cash Flow	10,316	-2,704	-520.51	-
Unlevered Free Cash Flow	10,351	-2,646	-446.09	-
Change in Working Capital	-2,447	-7,357	1,650	-176.2

Source: S&P Capital IQ. Standard template. Financial Sources.